Chemist & Druggist is part of the Informa Tech Division of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission. Printed by #UserName#, #Company_Name#


Printed By

UsernamePublicRestriction

James Waldron: Is there a bad time to celebrate success?

It's more important than ever to highlight your achievements, says James Waldron

Is there ever an inappropriate time for celebration? It’s a question I’ve been mulling over after a reader used an


How would adding antidepressants to the NMS benefit your patients?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

" target="_blank">online article on this year’s C+D Awards shortlist to ask whether, “at a time when our profession is being attacked”, it is really appropriate to host a “self-congratulatory” awards ceremony.

I get their point. Pharmacists have long been battling against the odds, whether it’s facing pressure from internal targets or scepticism from commissioners. With draconian cuts to pharmacy funding in England looming, continuing to host a ceremony celebrating the sector’s achievements may seem like tapping your toe to the Titanic’s resident band while the ship sinks.

But I’d argue that this tough climate makes it more important than ever to draw attention to each one of you who is going the extra mile for your patients every day. With many C+D readers expressing disillusionment with their current career, there isn’t a better time for pharmacists to share their trials and triumphs – whether that’s delivering medicines to housebound patients in person, or finding a fresh way to collaborate with other health professionals in their area.

I’m not just talking about the C+D Awards (obviously, I’m slightly biased on that account). From the Royal Pharmaceutical Society’s I Love My Pharmacist competition, returning for a third year, to the online phenomenon that was last month’s #pharmacy24 Twitter initiative, there is a plethora of ways that both frontline pharmacists and their representatives are continuing to put the sector in the spotlight. And let’s not forget the internal awards and reward schemes organised by chains and buying groups, or individual pharmacies’ trusty Employee of the Month accolades.

None of these should be seen as self-congratulatory back-slapping. No one goes to work expecting to win an award, but if you do get nominated then it’s not only a confidence boost, but a chance to share a success story with the rest of community pharmacy.

These initiatives shouldn’t continue in spite of the hardships faced by the sector, but because of them. As Pharmacy24 co-founder Mohammed Hussain puts it: “We wanted pharmacists to shout about what we do [and] what we’re passionate about.” I have to agree. The qualities of passion, innovation and great patient care should always be cause for celebration.
 


Did you enter the C+D Awards this year?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Pre-reg Trainee

Tonbridge, Kent

 Salary: £22,000

Apply Now
UsernamePublicRestriction

Register

CD000946

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel